Carbamazepine-induced acute generalized exanthematous pustulosis triggering diabetic ketoacidosis in a patient with type II diabetes mellitus: a case report

Key Points

• Acute generalized exanthematous pustulosis developed alongside diabetic ketoacidosis, complicating treatment.
• The simultaneous presence of AGEP and DKA poses unique challenges in patient management, with direct implications for care strategies.
• Management strategies must carefully consider the interplay between carbamazepine side effects and diabetes-related complications.
• Collaborative care approaches are essential to navigate the complexities of treating both conditions effectively.